Welcome to our dedicated page for Exelon SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating the cost of a nuclear refueling outage or tracking when an Exelon director buys shares can feel impossible in a 300-page disclosure. Questions like “Exelon insider trading Form 4 transactions” or “Exelon quarterly earnings report 10-Q filing” signal just how many places investors must look. Exelon’s mix of regulated utilities and competitive generation adds layers of rate-case data, carbon policy notes, and capacity auction results that bury critical signals.
Stock Titan’s AI-powered analysis turns that maze into a guided path. Need “Exelon 8-K material events explained” within minutes of release? We deliver real-time alerts straight from EDGAR. Curious about dividend safety? Our engine summarizes every “Exelon annual report 10-K simplified” section—capital spend, rate-base growth, decommissioning trusts—so you grasp the big picture without wading through legalese. Form 4 dashboards combine “Exelon Form 4 insider transactions real-time” with pattern recognition, letting you spot “Exelon executive stock transactions Form 4” before market chatter starts.
Whether you’re “understanding Exelon SEC documents with AI” for credit modeling or need an “Exelon proxy statement executive compensation” breakdown before voting season, the platform links each filing to actionable insights: segment EBITDA, storm-recovery riders, and hedging exposure. Add side-by-side comps, and you have an “Exelon earnings report filing analysis” that shows how weather or power prices moved the needle. No more scavenger hunts—just clear answers, continuously updated.
Exelon Corporation reported that it will change the vendor for its Employee Savings Plan (ESP) effective on or about December 22, 2025. To complete this transition, the company will impose a blackout period when ESP participants and beneficiaries cannot change contribution rates, move investments (including into or out of Exelon common stock), or request loans, withdrawals, or distributions from their ESP accounts.
The blackout period is expected to start at 4:00 p.m. Eastern Time on December 3, 2025 and end during the week of December 22, 2025. Exelon also notified its directors and executive officers that, during this blackout, they are prohibited from trading Exelon common stock or related derivative securities acquired in connection with their roles at the company. A formal blackout notice is filed as an exhibit, and investors can request details about the actual blackout dates from Exelon’s Corporate Secretary.
Exelon Corporation furnished an 8-K announcing its third-quarter results for the period ended September 30, 2025. The company released a press statement and supporting materials, which are included as Exhibit 99.1, and presentation slides as Exhibit 99.2. The materials are furnished under Items 2.02 and 7.01, not filed.
Exelon scheduled its Q3 2025 earnings conference call for 9:00 AM CT (10:00 AM ET) on November 4, 2025. Registration and replay access are available via the Investor Relations page at https://investors.exeloncorp.com.
Insider acquisition of deferred stock units by an Exelon director. Bryan K. Segedi, listed as a director, acquired 950 deferred stock units on 09/30/2025 at an indicated price of $43.43 per unit. Following the transaction he is reported to beneficially own 7,492 units indirectly under the Exelon Corp. Directors Deferred Stock Unit Plan; that balance includes 60 shares added through automatic dividend reinvestment. The filing reports the transaction as an acquisition of non-derivative deferred stock units as part of director compensation and records the holding as indirect ownership through the directors' plan.
Matthew C. Rogers, a director of Exelon Corp (EXC), received 950 deferred stock units on 09/30/2025 at a reported price of $43.43 each. The filing shows these units are held indirectly under the Exelon Corp. Directors Deferred Stock Unit Plan and increase Mr. Rogers' total reported balance to 10,542 units. The balance includes 88 shares acquired via automatic dividend reinvestment. The Form 4 was signed by David T. Skinner as attorney-in-fact on 10/01/2025.
Anna Richo, a director of Exelon Corp (EXC), received equity-based deferred compensation tied to Exelon common stock. On 09/30/2025 she was credited 950 deferred stock units at a reported price of $43.43, bringing her total indirect holdings in deferred stock units to 9,346 (that total includes 77 shares from dividend reinvestment). On the same date she was credited 694 phantom share equivalents694 underlying common shares$45.017,082 (including 55 accrued on the ex-dividend date). The transactions were reported on a Form 4 by an attorney-in-fact on behalf of the reporting person.
Insider acquisition and holding summary: Exelon director Linda P Jojo acquired 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. After the reported transaction, Ms. Jojo beneficially owns 53,270 shares (held indirectly). The filing notes that the balance includes 477 additional shares acquired through automatic dividend reinvestment. The Form 4 was submitted by David T. Skinner as attorney-in-fact and dated 10/01/2025.
David G. DeWalt, an Exelon Corp. director, reported an acquisition of 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit. Following the transaction, Mr. DeWalt beneficially owned 2,145 units indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan. The reported balance includes 11 additional shares acquired via automatic dividend reinvestment. The Form 4 was executed by David T. Skinner as attorney-in-fact and dated 10/01/2025.
Exelon Corp (EXC) director William P. Bowers reported transactions dated 09/30/2025. The filing shows he acquired 950 deferred stock units at $43.43 and acquired 1,805 phantom share equivalents in a non‑qualified deferred compensation plan valued at $45.01 per underlying share. He also disposed of 4,500 shares of common stock. Following these transactions he beneficially owned 17,838 shares indirectly (including 154 shares from dividend reinvestment) and directly held 17,097 phantom equivalents (including 133 credited on the ex‑dividend date). The phantom equivalents will be settled in cash upon termination of board service.
FAQ
What is the current stock price of Exelon (EXC)?
What is the market cap of Exelon (EXC)?
